Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
RoActemra (tocilizumab) - Important Safety Information from Roche Products (Ireland) Ltd as approved by HPRA
Notice type:
3rd Party Publications
Date:
28/06/2019
Problem Or Issue:
Important Safety Information from Roche Products (Ireland) Ltd on RoActemra (tocilizumab) : Rare risk of serious hepatic injury including acute liver failure requiring transplantation
Important Safety Information - RoActemra (tocilizumab)
« Back
Date Printed: 28/03/2024